Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

BizVibe Examines the Top Products and Companies in the Global Oncology Drug Market

Posted on: 06 Sep 17

The global oncology drug market has been one of the fastest growing segments in the pharmaceutical industry around the world. Driven by rising cancer rates over recent decades; in response, drug manufacturers have really advanced in technology. Leading oncology pharma companies are now developing and investing heavily into more advanced, effective, and affordable oncology drugs to improve cancer treatment. Details about some of the world’s leading oncology drug companies and top oncology drugs available on the market are some of this week’s top stories covered by BizVibe. BizVibe is the world’s smartest B2B marketplace and allows its users to discover high-quality leads, contact prospects, and source quotes in real time. Many leading pharmaceutical companies use BizVibe as their go-to B2B networking platform.

This Smart News Release features multimedia. View the full release here:

BizVibe Examines the Top Products and Companies in the Global Oncology Drug Market (Graphic: Business Wire)

Network with over 333,000 Pharma Companies on BizVibe

Top 10 Oncology Drugs Companies in 2017

With cancer rates on the rise around the world, many of the world’s leading pharmaceutical companies are increasing their effort and investment in the research and development of new, powerful and affordable oncology drugs. BizVibe identifies the top 10 major market leaders in the global oncology drug market and here are some of the top companies from that list:

10. Bristol-Meyers Squibb : BMS has a wide portfolio of oncology drugs, including BiCNU, CeeNU, Vrozia, Ixempra, Lysodren, Opdivo, and Empliciti. The company’s top-selling oncology drugs, Erbitux and Yervoy, generated USD 1.9 billion and USD 960 million respectively in 2016. The company generated total revenue of USD 16.56 billion last year.

9. Eli Lilly : Roughly USD 3.72 billion of Lilly’s total USD 21 billion revenue from 2016 was generated from the company’s oncology segment. Sales of its top-selling oncology drug, Almita, generated USD 2.5 billion last year. Almita is used for the treatment of non-small cell lung cancers.

8. AstraZeneca : In 2015, AstraZeneca was the world’s eighth-largest pharmaceutical company in the world in terms of revenue. Much of its revenue is generated through the sale of its oncology drugs and products, including Zoladex, which is used to treat prostate and breast cancers and accounts for USD 1 billion in sales annually.

7. AbbVie : AbbVie generated revenue of USD 25.63 billion in 2016, with approximately USD 1.83 billion of that coming from the oncology segment. In 2015, AbbVie acquired Pharmalytics, an oncology firm, and Pharmalytics’s blood cancer treatment, ibrutinib. Global sales of ibrutinib were projected to be worth USD 1 billion in 2016.

6. Celgene: Celgene specializes in the discovery and development of medicines for cancer and inflammatory disorders. In Q4 of 2016, the company’s net product sales totaled USD 2.98 billion, and the company employed more than 2,000 people. Celgene develops and manufactures Revlimid, one of the world’s best-selling oncology drugs, which was created to treat multiple myeloma. Sales of Revlimid total more than USD 4 billion annually.

Read the Rest of the List on BizVibe

Top 5 Oncology Drugs in the Global Pharmaceutical Industry

With the rise of cancer treatment around the world, the global oncology drug market has been growing at a rapid pace. The total sales of oncology drugs are expected to exceed USD 90 billion over the next five years. While pharmaceutical companies across the globe continue to develop and launch new products to the market, here are the top 5 oncology drugs currently available in the global pharmaceutical market as determined by BizVibe.

5. Imbruvica : This oncology drug is manufactured by Johnson & Johnson. Imbruvica generated USD 5.3 billion in sales last year and is used for the treatment of mantle cell lymphoma and chronic lymphocytic leukemia.

4. Revlimid : Manufactured by Celgene and generically known as lenalidomide, Revlimid is used for the treatment multiple myeloma, mantle cell lymphoma, and myelodysplastic syndromes. Revlimid generated sales of more than USD 4 billion last year and is projected to generate sales of over USD 13 billion in the next five years.

3. Herceptin : As another of Roche’s blockbuster drugs, Herceptin is used for the treatment of HER2+ breast cancer. Sales of Herceptin amounted to roughly USD 6.5 billion last year. Like Avastin, Herceptin’s global leading position may be threatened in the future by biosimilars such as Herzuma and Canmab.

Read the Rest of the List on BizVibe

In addition to oncology drug companies, BizVibe is home to more than seven million companies across 700+ industries. Using BizVibe’s platform, users can generate leads, short list prospects, network with businesses from around the world, and trade seamlessly. The BizVibe platform allows you to discover the highest quality leads and make meaningful connections with companies of interest, all in real-time. Claim your company profile for free and let BizVibe connect you with potential business partners. To make things as simple as possible, use the BizVibe Chatbot to create new business opportunities.

About BizVibe

The single-minded focus of BizVibe’s platform is to make networking easier. Over the years, we've searched far and wide to figure out how businesses connect and enable trade. That first interaction is usually fraught with the uncertainty of finding a potential partner vs. a potential nightmare. With this in mind, we've designed a robust set of tools to help companies generate leads, shortlist prospects, network with businesses from around the world and trade seamlessly.

BizVibe is headquartered in Toronto and has offices in London, Bangalore, and Beijing. For more information on the BizVibe network, please contact us.

View source version on

Business Wire

Last updated on: 06/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.